激活剂

蛇毒蛋白C激活剂实验条件及稳定性的探讨

Research on the Experimental Conditions and Stability of Protein C Activator Isolated from Snake Venom

蛇毒蛋白C激活剂的活化蛋白C特性及影响因素的探讨

Research on the Protein C-Activating Property and Influencial Factors of Protein C Activator Isolated from the Venom of Agkistrodon halys

蛋白激酶C激活剂和抑制剂对肿瘤坏死因子杀瘤活性的影响

Effects of protein kinase C activators and inhibitors on tumor necrosis factor cytotoxicity

核转录因子κB受体激活剂可能通过新的信号途径调节破骨细胞分化

Osteoclast Differentiation Regulated by Receptor Activator of Nuclear Factor κ B Probably Through A Novel Signaling Pathway

RT-PCR检测胃癌组织中尿激酶型纤溶酶原激活剂mRNA水平表达

Expression of Urokinase-type Plasminogen Activator mRNA in Gastric Cancer Tissues

血尿激酶型纤溶酶原激活剂mRNA水平表达与乳腺癌及其淋巴结转移的关系

Study on Relationship Between mRNA of Urokinase-Type Plasminogen Activator and Breast Cancer , Lymph Nodes Metastasis

共激活剂Br~-，I~-对ZnS：Mn，Cu·X发光中心的影响

Effect of Activator and Co activator on the Luminescence Center of ZnS : Mn , Cu Material

激活剂Cu和Mn对ZnS相变和微结构的影响

Effect of activator Cu or Mn on phase transition and microstructure of ZnS

RT-PCR测定组织纤溶酶原激活剂突变体（La-tPA）在转基因鼠乳腺表达的研究

La tRA Expression Determination by RT PCR in Mammary Gland of Transgenic Mice

心血管ATP敏感性钾通道及其激活剂和拮抗剂

ATP sensitive potassium channels in cardiovascular system and the activators and antagonists

关节盘前移位对关节滑膜尿激酶型纤溶酶原激活剂及其1型抑制剂mRNA表达的影响

Effect of Disc Displacement on mRNA Expression of Urokinase Plasminogen Activator and Its Inhibitor - 1 in Synovial Tissues

目的：探讨蝮蛇蛇毒蛋白C激活剂对心肌梗死发生后血液凝固性的影响及其机制。

Objective : To investigate the effects and mechanisms of protein C activator from the venom of agkistrodon halys on blood coagulation after the myocardial infarction .

EGF对小鼠角质形成细胞中组织型纤溶酶原激活剂表达的调节

Regulation of tissue plasminogen activator expression by EGF in epidermal keratinocytes of mouse

MCF-7细胞中组织型纤溶酶原激活剂乳腺特异性表达载体的瞬时表达

Transient expression of tissue-type plasminogen activator in mammary carcinoma cell line MCF-7

雷公藤多苷对佐剂性关节炎模型大鼠关节中核因子κB受体激活剂配基表达的影响

Effect of Glycoside of Tripterygium wilfordii hook . F on Expression of Receptor Activator of Nuclear Factor - κ B Ligand and Osteoprotegerin in Joints of Rat Adjuvant Induced Arthritis

电致发光主要是在以ZnS等为基质的半导体材料中加入少量Cu、Mn等激活剂后在电场作用下发光。

Electroluminescence is based on the semiconductor materials such as ZnS doped with Cu and Mn driven by electric field .

组织型纤溶酶原激活剂（t-PA）及其突变体的表达研究进展

Progresses in the Expression of Tissue-Type Plasminogen Activator and Its Mutants

Mg2＋，Ca2＋是酶的激活剂，Cu2＋是酶的抑制剂，EDTA对该酶也有明显的抑制作用。

Mg2 + and Ca2 + can activate the enzyme although Cu2 + and EDTA inhibit it .

PPARγ激活剂罗格列酮对兔动脉粥样硬化斑块消退的影响

Effect of PPAR γ agonist rosiglitazone on regression of the atherosclerotic plaques in rabbits

野生型组织型纤溶酶原激活剂（t-PA）工程细胞株生物学特性分析

The analysis of biological characteristics for the wild-type t-PA engineering cell lines

组织型纤溶酶原激活剂（t-PA）、纤溶酶原激活剂抑制剂（PAI）均是体内纤溶系统的重要组成部分。

PAI and t-PA are important constituents of fibrinolytic system in human body .

在植物系统获得抗性（SAR）激活剂筛选中，可采用离体测定和活体盆栽测定相结合的方法进行。

The combination of in vitro with in vivo test could be adopted in the screening of plant SAR ( systemic acquired resistance ) activators .

载脂蛋白AI、组织型纤溶酶原激活剂显著低于对照组（P＜0.001和P＜0.01）。

The concentration of Apo A I and t PA activity were obviously lower than those of the controls ( p < 0 001 and 0 01 , respectively ) .

尿激酶型纤溶酶原激活剂（uPA）系统在子宫内膜癌中的研究进展

Study On uPA System in the Carcinoma of Endometrium

抗PAI抑制作用的组织纤溶酶原激活剂在大肠杆菌中的表达

Expression and activity of tissue-type plasminogen activator mutant reteplase with deletion of PAI-1 binding sites

目的探讨环化酶激活剂（前列腺素E1、腺苷及Zn2+离子）对周围神经损伤后感觉神经元的保护作用。

To observe the protective effect of cyclase activator on sensory neurons after peripheral nerve injury .

然而，它对多克隆激活剂引起的T细胞表面分子CD3的下调无明显影响。

However , it did not have any significant effect on T cell surface molecule CD3 down-regulation .

一个组织型纤溶性溶解酶原激活剂（T-pa）非共价类抑制剂的药效模型

A Feature Based Pharmacophore for Tissue - type Plasminogen Activator non - covalent Inhibitor

组织型纤溶酶原激活剂&膜联蛋白A5融合基因的构建

Construction of Tissue Plasminogen Activator-annexin A5 Fusion Gene

组织型纤溶酶原激活剂（t-PA）对实验性青光眼滤过性手术瘢痕形成的影响

Effects of tissue plasminogen activator ( t-PA ) on scar formation after experimental filtration surgery